| Patents for C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041) |
|---|
| 03/07/2002 | WO2002018383A2 Aza heterocyclic derivatives and their therapeutic use |
| 03/07/2002 | WO2002017916A1 Antiviral and antimicrobial guanidine or biguanidine derivatives |
| 03/07/2002 | US20020028943 For lowering serum lipid, cholesterol and/or triglyceride levels; treating atherosclerosis |
| 03/07/2002 | US20020028815 Novel multicyclic compounds and the use thereof |
| 03/06/2002 | EP1183245A1 Selective npy (y5) antagonists |
| 03/06/2002 | CN1338934A Mono-acyloxy aralkyl neuronuscular relaxants |
| 03/06/2002 | CN1338499A Bispirocyclo derivative and its application in electroluminescent material |
| 03/05/2002 | CA2272138C Pyrazolopyrimidine and pyrazolopyridine compounds having crf antagonist activity |
| 02/28/2002 | WO2001046200A8 Novel piperidine and piperazine derivatives |
| 02/28/2002 | WO2001030782A3 Novel herbicides |
| 02/28/2002 | WO2001017614A3 Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents |
| 02/28/2002 | US20020026047 For use in Hydrogen Bonding Liquid Chromatography, environmental remediation by removal of undesired ions or neutral molecules, removal of phosphate for kidney dialysis, drug delivery, separation |
| 02/28/2002 | DE10040242A1 Simplified preparation of curcurbituril comprises reacting a mixture of concentrated sulfuric acid, acetylene diurea and formaldehyde without the addition of water |
| 02/27/2002 | EP1180991A2 Gambogic acid, analogs and derivatives as activators of caspases and inducers of apoptosis |
| 02/27/2002 | CN1337960A Piperdine and piperazine derivatives as inhibitors of the ABETA fibril formation |
| 02/26/2002 | CA2081605C Complex salts of hematoporphyrin and of its derivatives, their synthesis and therapeutic agent |
| 02/21/2002 | WO2002014317A2 Substituted pyrazoles |
| 02/21/2002 | WO2002014315A2 Substituted pyrazoles |
| 02/21/2002 | CA2419550A1 Substituted pyrazoles |
| 02/19/2002 | US6348595 Perylene-3,4,9,10-tetracarboximide is hydroxymethylated by reaction with formaldehyde to form bis(hydroxymethyl) perylene-3,4,9,10-tetracarboximide; one pot process |
| 02/14/2002 | WO2002012237A2 Process for preparing 2-(4-pyridyl)amino-6-dialkyloxyphenyl-pyrido[2,3-d]pyrimidin-7-ones |
| 02/14/2002 | WO2002012223A2 Synthetic salicylihalamides, apicularens and derivatives thereof |
| 02/14/2002 | WO2002012195A1 Derivatives of 1,2-dihydro-7-hydroxyquinolines containing fused rings |
| 02/14/2002 | US20020019544 Bioavailability |
| 02/14/2002 | US20020019526 Pyrrolo[2,3-d]pyrimidine compounds |
| 02/14/2002 | CA2417994A1 Synthetic salicylihalamides, apicularens and derivatives thereof |
| 02/14/2002 | CA2417937A1 Process for preparing 2-(4-pyridyl)amino-6-dialkyloxyphenyl-pyrido[2,3-d]pyrimidin-7-ones |
| 02/14/2002 | CA2417816A1 Derivatives of 1,2-dihydro-7-hydroxyquinolines containing fused rings |
| 02/13/2002 | EP1049695B1 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors |
| 02/13/2002 | CN1335850A Quinoline derivatives |
| 02/12/2002 | US6346526 Carbapenicillin with 1,1-dioxo-2,3-dihydronaphtho(1,8-de)(1,2)thiazin-2-yl-substituent; treating staphylococcus infections resistant to methicillin; side effect reduction |
| 02/12/2002 | US6346525 Carbapenicillin with 1,1-dioxo-2h-1-thia-2,3-diaza-naphthalene substituent; treating staphylococcus infections resistant to methicillin; side effect reduction |
| 02/07/2002 | WO2002009758A2 Inhibitors of cellular efflux pumps of microbes |
| 02/07/2002 | WO2000072802A3 Water soluble multi-biotin-containing compounds |
| 02/07/2002 | CA2417799A1 Inhibitors of cellular efflux pumps of microbes |
| 01/31/2002 | WO2002008215A1 Hyperpolarizable organic chromophores |
| 01/31/2002 | US20020013319 For therapy of tumor or restenosis |
| 01/31/2002 | DE19881732C1 New phosphodiesterase inhibiting 2-phenyl-imidazotriazinone derivatives useful for treating e.g. cardiovascular, cerebrovascular and/or urogenital diseases |
| 01/31/2002 | CA2417000A1 Hyperpolarizable organic chromophores |
| 01/30/2002 | CN1333776A Imidazo [4,5-b] pyridiniummethyl-containing cephem compounds having broad antibacterial spectrum |
| 01/29/2002 | US6342601 Treating allograft rejection, rheumatoid arthritis |
| 01/24/2002 | WO2002006361A2 Novel photochromic polymers and methods of synthesizing same |
| 01/24/2002 | WO2002006282A1 Molecules capable of binding to telomere and the like and method with the use of the same |
| 01/24/2002 | WO2002005953A2 Asymmetric synthetic methods based on phase transfer catalysis |
| 01/24/2002 | WO2001042505A3 Fluorescent quenching detection reagents and methods |
| 01/24/2002 | WO2001032655A3 Quinoline and naphthyridine carboxylic acid antibacterials |
| 01/24/2002 | WO2001023357A3 Fused cycloheptane and fused azacycloheptane compounds and their use as integrin receptor antagonists |
| 01/24/2002 | US20020010176 Integrin receptor antagonists |
| 01/23/2002 | EP1174431A2 2-Phenyl-substituited Imidazotriazinones as Phoshodiesterase Inhibitors |
| 01/23/2002 | EP1135395A4 Crystalline salts of a carbapenem antibiotic |
| 01/23/2002 | CN1332744A Tricyclic delta 3-piperidines as alpha 2-antagonists |
| 01/22/2002 | US6340745 Phthalocyanine and use of phthalocyanine as a marking agent |
| 01/17/2002 | WO2002004465A1 Methods and kits for the detection of arginine compounds |
| 01/17/2002 | WO2002004464A1 Novel cephalosporin compounds and process for preparing the same |
| 01/17/2002 | WO2001047922A3 Azaindoles |
| 01/17/2002 | WO2001044235A3 Agents and methods for the treatment of proliferative diseases |
| 01/17/2002 | US20020006923 Thrombin inhibitors |
| 01/17/2002 | CA2415174A1 Methods and kits for the detection of arginine compounds |
| 01/17/2002 | CA2409337A1 Novel cephalosporin compounds and process for preparing the same |
| 01/16/2002 | EP1171442A1 Xanthine derivatives and analogs as cell signalling inhibitors |
| 01/16/2002 | EP1171135A1 6-azaindole compounds as antagonists of gonadotropin releasing hormone |
| 01/16/2002 | CN1331694A Antihistaminic spiro compounds |
| 01/10/2002 | WO2002002563A2 Substituted-triazolopyrimidines as anticancer agents |
| 01/10/2002 | WO2002002560A2 Purine-2,6-diones which are inhibitors of the enzyme dipeptidyl peptidase iv (dpp-iv) |
| 01/10/2002 | WO2002002557A2 2-phenylimidazo[1,2-a]pyridine derivatives: a new class of gaba brain receptor ligands |
| 01/10/2002 | WO2001034604A3 Adenosine receptor antagonists and methods of making and using the same |
| 01/10/2002 | WO2001034603A3 Bicyclic and tricyclic heteroaromatic compounds |
| 01/10/2002 | CA2413802A1 Substituted-triazolopyrimidines as anticancer agents |
| 01/03/2002 | WO2002000656A2 Pirazino '1$m(1)2$m(1) :1, 6! pyrido '3,4-b! indole derivatives |
| 01/03/2002 | WO2002000653A2 Fused cyclic compounds as modulators of nuclear hormone receptor function |
| 01/03/2002 | WO2002000626A1 Fused azepine derivatives and their use as antidiuretic agents |
| 01/03/2002 | WO2002000617A2 Selective androgen receptor modulators and methods for their identification, design and use |
| 01/03/2002 | WO2002000616A2 Novel cephalosporin compounds and process for preparing the same |
| 01/03/2002 | US20020002170 Piperidine and piperazine derivatives as inhibitors of the abeta fibril formation |
| 01/03/2002 | US20020002169 Protein kinase inhibitors |
| 01/03/2002 | CA2413417A1 Selective androgen receptor modulators and methods for their identification, design and use |
| 01/03/2002 | CA2412555A1 Fused azepine derivatives and their use as antidiuretic agents |
| 01/03/2002 | CA2411714A1 Novel cephalosporin compounds and process for preparing the same |
| 01/02/2002 | EP1165563A1 Bicyclic heterocycles, method for producing them and their use as herbicides and pharmaceutical agents |
| 01/02/2002 | EP1165562A1 Cyclic substituted fused pyrrolocarbazoles and isoindolones |
| 01/02/2002 | EP1165521A1 FUSED PYRIDOPYRIDAZINE INHIBITORS OF cGMP PHOSPHODIESTERASE |
| 01/02/2002 | EP1165076A1 6-azaindole compounds as antagonists of gonadotropin releasing hormone |
| 01/02/2002 | EP1165075A1 6-azaindole compounds as antagonists of gonadotropin releasing hormone |
| 01/02/2002 | EP0892801B1 Acridone-derived compounds useful as antineoplastic and antiretroviral agents |
| 01/01/2002 | US6335345 Spiro compounds |
| 01/01/2002 | CA2142869C Trifluoromethylpyrroloindolecarboxylic acid ester and process for production thereof |
| 12/27/2001 | WO2001097618A2 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives, taxanes and/or antimetabolites |
| 12/27/2001 | CA2412054A1 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives, taxanes and/or antimetabolites |
| 12/25/2001 | CA2058592C Antibacterial agents |
| 12/19/2001 | EP1162970A2 Anti-inflammatory uses of manzamines |
| 12/13/2001 | WO2001094350A1 6-phenylpyrrolopyrimidinedione derivatives |
| 12/13/2001 | WO2001055719A3 Diagnostic kit for detecting creatine levels |
| 12/13/2001 | WO2001039742A3 Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof |
| 12/13/2001 | CA2411013A1 6-phenylpyrrolopyrimidinedione derivatives |
| 12/12/2001 | EP1161431A1 6-azaindole compounds as antagonists of gonadotropin releasing hormone |
| 12/12/2001 | EP0767790B1 Condensed imidazole compounds, their production and use |
| 12/11/2001 | US6329385 Antiinflammatory agents, antiarthritic agents, viral diseases and gastrointestinal disorders |
| 12/06/2001 | WO2001092256A1 2,7-naphthyridine derivatives |
| 12/06/2001 | WO2001017999A3 Amino-triazolopyridine derivatives |
| 12/06/2001 | CA2409617A1 2,7-naphthyridine derivatives |